Transplantation in Parkinson's Disease


  • J. Stephen Fink

    Corresponding author
    1. Diacrin, Inc., Charlestown, and Department of Neurology, Harvard Medical School, and Movement Disorder Unit, Massachusetts General Hospital, Boston, Massachusetts, U.S.A
    Search for more papers by this author

2 Vice President and Director, Clinical Research, Diacrin, Inc., Building 96. 13th Street, Charlestown Navy Yard, Charlestown, Massachusetts 02129, U.S.A.


Abstract: The modification of nervous system function by cell replacement and the introduction of heterologous genes are being developed as possible therapeutic approaches in degenerative diseases of the nervous system. The use of cellular transplantation in the nervous systemof patients with neurodegenerative diseases will be reviewed with an emphasis on Parkinson's disease.